erythromycin has been researched along with chloroquine in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (32.61) | 18.7374 |
1990's | 5 (10.87) | 18.2507 |
2000's | 11 (23.91) | 29.6817 |
2010's | 14 (30.43) | 24.3611 |
2020's | 1 (2.17) | 2.80 |
Authors | Studies |
---|---|
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
Dunne, MW; Fidock, DA; Nkrumah, LJ; Sacchettini, JC; Sidhu, AB; Sun, Q | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Pratim Roy, P; Roy, K | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Boonlarppradab, C; Choowong, W; Kornsakulkarn, J; Saepua, S; Suriyachadkun, C; Thongpanchang, C | 1 |
Warhurst, DC | 1 |
Peters, W; Robinson, BL; Warhurst, DC | 2 |
Gingras, BA; Jensen, JB | 2 |
Brandling-Bennett, AD; Khan, B; Koech, DK; Ojoo, P; Oloo, AJ; Watkins, WM | 1 |
Attanath, P; Benjasurat, Y; Karbwang, J; Looareesuwan, S; Phillips, RE; Warrell, DA; White, NJ | 1 |
Brandling-Bennett, AD; Khan, B; Oloo, AJ; Watkins, WM | 1 |
Rolfe, M | 1 |
Gershon, P; Howells, RE | 1 |
Boudreau, EF; Childs, GE; Pang, LW; Somutsakorn, P; Supanantalerk, C; Webster, HK | 1 |
Hainton, JM; Hawkins, SE | 1 |
Robinson, BL; Warhurst, DC | 1 |
Fabre, J | 1 |
Boĭko, GF; Savel'ev, IA; Zolotarev, AE | 1 |
Knight, R | 1 |
Karbwang, J; Kasemsarn, P; Looareesuwan, S; Phillips, RE; Warhurst, DC; Warrell, DA; White, NJ | 1 |
Gershon, PD; Howells, RE | 1 |
Van Dyke, K; Ye, Z | 1 |
Hargreaves, CA; Hills, F; Homa, ST; Howell, RJ; Rahman, F; Rogers, S | 1 |
Puri, SK; Singh, N | 1 |
Alihodžić, S; Almela, MJ; Herreros, E; Jelić, D; Perić, M; Pešić, D; Spaventi, R; Starčević, K; Toplak, A; Vidal, J | 1 |
Du Plessis, LH; Kotzé, AF; Maritz, MM; van Niekerk, AC | 1 |
Goodman, CD; Gramajo, H; Labadie, GR; McFadden, GI; Peirú, S; Rodríguez, E; Useglio, M | 1 |
1 review(s) available for erythromycin and chloroquine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
45 other study(ies) available for erythromycin and chloroquine
Article | Year |
---|---|
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin.
Topics: Amodiaquine; Animals; Antimalarials; Azithromycin; DNA, Protozoan; Drug Resistance; Erythrocytes; Humans; Malaria, Falciparum; Models, Structural; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.
Topics: Algorithms; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Enzyme Inhibitors; Factor Analysis, Statistical; Least-Squares Analysis; Linear Models; Models, Molecular; Neural Networks, Computer; Quantitative Structure-Activity Relationship; Reproducibility of Results | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Antimicrobial and Cytotoxic Angucyclic Quinones from
Topics: Actinomadura; Anti-Infective Agents; Antineoplastic Agents; Cell Line, Tumor; Humans; Magnetic Resonance Spectroscopy; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolones | 2021 |
Chloroquine-erythromycin potentiation in P. berghei.
Topics: Animals; Chloroquine; Drug Resistance, Microbial; Drug Synergism; Erythromycin; Plasmodium berghei | 1977 |
The chemotherapy of rodent malaria, XXIV. The blood schizontocidal action of erythromycin upon Plasmodium berghei.
Topics: Animals; Chloroquine; Drug Resistance; Drug Synergism; Erythrocytes; Erythromycin; Malaria; Male; Mice; Plasmodium berghei | 1976 |
Activity of azithromycin (CP-62,993) and erythromycin against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro.
Topics: Animals; Antiprotozoal Agents; Azithromycin; Chloroquine; Drug Interactions; Drug Resistance; Erythromycin; Plasmodium falciparum | 1992 |
Plasmodium falciparum sensitivity to erythromycin and 4-aminoquinoline combinations in vitro.
Topics: Aminoquinolines; Animals; Antimalarials; Chloroquine; Drug Interactions; Erythromycin; Plasmodium falciparum | 1991 |
Intravenous amodiaquine and oral amodiaquine/erythromycin in the treatment of chloroquine-resistant falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Amodiaquine; Child; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Erythromycin; Humans; Injections, Intravenous; Malaria; Middle Aged; Plasmodium falciparum | 1985 |
Failure of erythromycin to improve chloroquine treatment of Plasmodium falciparum malaria in Kenya.
Topics: Animals; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Erythromycin; Humans; Infant; Kenya; Malaria; Plasmodium falciparum | 1988 |
Multiple drug resistant Plasmodium falciparum malaria in a pregnant indigenous Zambian woman.
Topics: Adult; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Erythromycin; Female; Humans; Malaria; Mefloquine; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 1988 |
Synergy of four macrolide antibiotics with chloroquine against chloroquine-resistant Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance, Microbial; Drug Synergism; Erythromycin; Leucomycins; Oleandomycin; Plasmodium falciparum; Tylosin | 1986 |
Failure of large-dose erythromycin in combination with a standard dose of chloroquine or quinine in the treatment of human falciparum malaria.
Topics: Adult; Chloroquine; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Humans; Malaria; Male; Plasmodium falciparum; Quinine; Thailand | 1985 |
Sensitivity of amoebae to chloroquine or erythromycin.
Topics: Amoeba; Animals; Cell Division; Chloroquine; Clone Cells; Cytoplasm; Erythromycin; Microbial Sensitivity Tests; Microinjections; Microsomes; Species Specificity; Subcellular Fractions; Time Factors | 1972 |
Antimalarial activity of erythromycin.
Topics: Animals; Chloroquine; Drug Resistance, Microbial; Erythromycin; Malaria; Mice | 1972 |
[Drugs and renal function].
Topics: Biotransformation; Cephaloridine; Chloroquine; Chlortetracycline; Colistin; Creatinine; Doxycycline; Erythromycin; Glomerular Filtration Rate; Humans; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Pharmacology; Streptomycin; Tetracycline | 1967 |
[Clinical course and treatment of biliary tract lambliasis].
Topics: Biliary Tract Diseases; Chloroquine; Erythromycin; Female; Giardiasis; Humans; Male | 1967 |
The chemotherapy of amoebiasis.
Topics: Acetanilides; Amebiasis; Amebicides; Arsenicals; Carrier State; Chloroquine; Dysentery, Amebic; Emetine; Entamoebiasis; Erythromycin; Furans; Humans; Hydroxyquinolines; Metronidazole; Nitroimidazoles; Paromomycin; Tetracyclines; Tinidazole | 1980 |
Failure of chloroquine-erythromycin and chloroquine-tetracycline combinations in treatment of chloroquine-resistant falciparum malaria in eastern Thailand.
Topics: Adolescent; Adult; Child; Chloroquine; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Tetracycline; Thailand | 1984 |
Combination of the antibiotics erythromycin and tetracycline with three standard antimalarials against Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Plasmodium falciparum; Tetracycline | 1984 |
The blood schizontocidal action of erythromycin against Plasmodium knowlesi infections in Macaca mulatta.
Topics: Animals; Blood; Chloroquine; Erythromycin; Macaca mulatta; Malaria; Male; Plasmodium | 1983 |
Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei.
Topics: Animals; Antiprotozoal Agents; Azithromycin; Chloroquine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Erythromycin; Malaria; Male; Mice; Plasmodium berghei; Specific Pathogen-Free Organisms | 1993 |
Interaction of artemisinin and tetracycline or erythromycin against Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Drug Synergism; Erythromycin; Plasmodium falciparum; Protein Synthesis Inhibitors; Sesquiterpenes; Tetracycline | 1994 |
Effects of co-trimoxazole, erythromycin, amoxycillin, tetracycline and chloroquine on sperm function in vitro.
Topics: Acrosome Reaction; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antimalarials; Cell Survival; Chloroquine; Dose-Response Relationship, Drug; Erythromycin; Humans; Male; Sperm Motility; Spermatozoa; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Azithromycin; Chloroquine; Doxycycline; Erythromycin; Female; Macaca mulatta; Malaria; Male; Mice; Parasitemia; Plasmodium cynomolgi; Plasmodium yoelii; Primaquine; Pyrimethamine | 2000 |
Design, synthesis, and in vitro activity of novel 2'-O-substituted 15-membered azalides.
Topics: Anti-Bacterial Agents; Antimalarials; Aza Compounds; Cell Line, Tumor; Chloroquine; Drug Resistance; Erythromycin; Gram-Positive Bacteria; Humans; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2012 |
In vitro activity of Pheroid vesicles containing antibiotics against Plasmodium falciparum.
Topics: Antimalarials; Azithromycin; Chloroquine; Drug Delivery Systems; Drug Resistance; Erythromycin; Inhibitory Concentration 50; Lipids; Particle Size; Plasmodium falciparum; Solubility; Time Factors | 2012 |
Chemobiosynthesis of new antimalarial macrolides.
Topics: Antimalarials; Azithromycin; Chloroquine; Drug Resistance; Erythromycin; Macrolides; Malaria; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum | 2013 |